Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Pyronaridine is an antimalarial agent.1 It is active against six P. falciparum drug-sensitive or -resistant strains (IC50s = 1.53-3.94 nM). Pyronaridine (3, 6, and 8 mg/kg) in combination with artesunate (Item No. 11817) reduces parasitemia in P. chabaudi-infected mice. It inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in infected A459 cells overexpressing angiotensin-converting enzyme 2 (ACE2; IC50 = 198 nM).2 Pyronaridine is also cytotoxic against a panel of human cancer cells lines, including breast, ovarian, and lung cancer cells, with 50% cytotoxic concentration values (CC50s) ranging from 1.6 to 9.4 µM.3 Formulations containing pyronaridine have been used in the treatment of malaria.
WARNING This product is not for human or veterinary use.
1. Anti-
2. Repurposing the ebola and marburg virus inhibitors tilorone, quinacrine, and pyronaridine: In vitro activity against SARS-
3. Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis. PLoS One 13(11), e0206467 (2018).